Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Next revisionBoth sides next revision
home:patients:glossary [01.09.2014] joyfulhome:patients:glossary [03.21.2016] – [Glossary] sallieq
Line 21: Line 21:
   * **autoimmune** – A condition or disease thought to arise from an overactive immune response of the body against substances and tissues normally present in the body.   * **autoimmune** – A condition or disease thought to arise from an overactive immune response of the body against substances and tissues normally present in the body.
   * **Autoimmunity Research Foundation** – Non-profit foundation dedicated to exploring a pathogenesis and therapy for chronic disease.   * **Autoimmunity Research Foundation** – Non-profit foundation dedicated to exploring a pathogenesis and therapy for chronic disease.
-  * **azithromycin (Zithromax)** – Bacteriostatic antibiotic **no longer** used by Marshall Protocol patients. Has relatively long half-life. 
-  * **Bactrim DS** – Sulfa antibiotic used by patients on the Marshall Protocol. Combination of sulfamethoxazole and trimethoprim. Works by locking bacterial folic acid synthesis. 
   * **beta-Defensin** – An antimicrobial peptide found primarily in immune cells and transcribed by the Vitamin D Receptor.   * **beta-Defensin** – An antimicrobial peptide found primarily in immune cells and transcribed by the Vitamin D Receptor.
   * **biofilm** – A structured community of microorganisms encapsulated within a self-developed protective matrix and living together.   * **biofilm** – A structured community of microorganisms encapsulated within a self-developed protective matrix and living together.
Line 34: Line 32:
   * **chlorogenic acid** – An antioxidant and phenolic compound, which in ways that are not yet fully clear, can modulate and/or suppress the immune response.   * **chlorogenic acid** – An antioxidant and phenolic compound, which in ways that are not yet fully clear, can modulate and/or suppress the immune response.
   * **chronic bacteria/infection/disease** –  In the context of the Marshall Pathogenesis, the term chronic is often used to refer to bacterial infections which persist over a long period of time, often decades. Chronic bacteria are harder to detect and, according to the Marshall Pathogenesis, play a central role in driving chronic inflammatory disease. Examples of chronic diseases include kidney disease, cancer, diabetes, and any of the other dozens of diseases which the MP addresses. //See acute infection.//   * **chronic bacteria/infection/disease** –  In the context of the Marshall Pathogenesis, the term chronic is often used to refer to bacterial infections which persist over a long period of time, often decades. Chronic bacteria are harder to detect and, according to the Marshall Pathogenesis, play a central role in driving chronic inflammatory disease. Examples of chronic diseases include kidney disease, cancer, diabetes, and any of the other dozens of diseases which the MP addresses. //See acute infection.//
-  * **clindamycin** – Bacteriostatic antibiotic used by patients on the Marshall Protocol.  
   * **cognitive dysfunction** – The loss of intellectual functions, such as reasoning, memory loss, and other neurological abilities, that is severe enough to interfere with daily functioning.   * **cognitive dysfunction** – The loss of intellectual functions, such as reasoning, memory loss, and other neurological abilities, that is severe enough to interfere with daily functioning.
   * **corticosteroids** – A first-line treatment for a number of diseases. Corticosteroids work by slowing the innate immune response. This provides some patients with temporary symptom palliation, but exacerbates the disease over the long-term by allowing chronic pathogens to proliferate.   * **corticosteroids** – A first-line treatment for a number of diseases. Corticosteroids work by slowing the innate immune response. This provides some patients with temporary symptom palliation, but exacerbates the disease over the long-term by allowing chronic pathogens to proliferate.
   * **cytokines** – Any of various protein molecules secreted by cells of the immune system that serve to regulate the immune system.   * **cytokines** – Any of various protein molecules secreted by cells of the immune system that serve to regulate the immune system.
-  * **demeclocycline** – Bacteriostatic antibiotic used by patients on the Marshall Protocol. 
   * **endotoxin** – A toxin associated with the outer membranes of bacteria, especially gram-negative bacteria. When these bacteria are destroyed, as will happen during the MP, endotoxins are released, causing a spike in symptoms known as the immunopathological reaction.   * **endotoxin** – A toxin associated with the outer membranes of bacteria, especially gram-negative bacteria. When these bacteria are destroyed, as will happen during the MP, endotoxins are released, causing a spike in symptoms known as the immunopathological reaction.
   * **familial aggregation** – Occurrence of a given trait shared by members of a family (or community) that cannot be readily accounted for by chance.   * **familial aggregation** – Occurrence of a given trait shared by members of a family (or community) that cannot be readily accounted for by chance.
Line 61: Line 57:
   * **metagenomic microbiota** – The community of bacterial pathogens, including those in an intracellular and biofilm state which cause chronic disease.   * **metagenomic microbiota** – The community of bacterial pathogens, including those in an intracellular and biofilm state which cause chronic disease.
   * **microbiota** – The bacterial community which causes chronic diseases; one which almost certainly includes multiple species and bacterial forms.   * **microbiota** – The bacterial community which causes chronic diseases; one which almost certainly includes multiple species and bacterial forms.
-  * **minimum inhibitory concentration (MIC)** – The lowest concentration of an antimicrobial that will inhibit the visible growth of a microorganism after overnight incubation. Dosing at well below the MIC improves the MP's effectiveness against slow-growing chronic pathogens and reduces the likelihood of resistance. +  * **minocycline** – Bacteriostatic antibiotic occasionally prescribed for some Marshall Protocol patients as a palliative.
-  * **minocycline** – Bacteriostatic antibiotic used by Marshall Protocol patients.+
   * **murine model** – A model of disease which uses rats or mice to mimic human conditions.   * **murine model** – A model of disease which uses rats or mice to mimic human conditions.
   * **neurological immunopathology** – A temporary exacerbation of neurological symptoms due to bacterial death.   * **neurological immunopathology** – A temporary exacerbation of neurological symptoms due to bacterial death.
Line 72: Line 67:
   * **photosensitivity** – Abnormal sensitivity to sunlight and bright lights. Also referred to as "sun flare" or "light flare."   * **photosensitivity** – Abnormal sensitivity to sunlight and bright lights. Also referred to as "sun flare" or "light flare."
   * **previtamin D3** – Largely inactive vitamin D metabolite, naturally occurring in the human body. When exposed to ultraviolet radiation converted into 25-D. Also known as 7-dehydrocholesterol.   * **previtamin D3** – Largely inactive vitamin D metabolite, naturally occurring in the human body. When exposed to ultraviolet radiation converted into 25-D. Also known as 7-dehydrocholesterol.
-  * **pulsed low dosing** – Administration of an antibiotic periodically, such as every 48 hours and in amounts small enough that the immunosuppressive effects of the antibiotics are minimized. 
   * **Pregnane Xenobiotic Receptor (PXR)** – Nuclear receptor which inhibits conversion of pre-vitamin D to 25-D, causing 25-D levels to drop via the CYP27A1 pathway. More significantly though, it transcribes CYP3A4, an enzyme which breaks down 1,25-D.   * **Pregnane Xenobiotic Receptor (PXR)** – Nuclear receptor which inhibits conversion of pre-vitamin D to 25-D, causing 25-D levels to drop via the CYP27A1 pathway. More significantly though, it transcribes CYP3A4, an enzyme which breaks down 1,25-D.
   * **quercetin** – Antioxidant supplement taken by some Marshall Protocol patients to limit intolerable immunopathology. Quercetin inhibits production of Nuclear Factor-kappa B, an inflammatory cytokine.   * **quercetin** – Antioxidant supplement taken by some Marshall Protocol patients to limit intolerable immunopathology. Quercetin inhibits production of Nuclear Factor-kappa B, an inflammatory cytokine.
Line 83: Line 77:
   * **Th1 Pathogens* ** – The community of bacterial pathogens which cause chronic inflammatory disease; one which almost certainly includes multiple species and bacterial forms.   * **Th1 Pathogens* ** – The community of bacterial pathogens which cause chronic inflammatory disease; one which almost certainly includes multiple species and bacterial forms.
   * **Th1 Spectrum Disorder* ** – The overlap of different disease symptoms in different patients with similar diagnoses--caused by the fact that any one bacterial species can contribute to numerous disease states.   * **Th1 Spectrum Disorder* ** – The overlap of different disease symptoms in different patients with similar diagnoses--caused by the fact that any one bacterial species can contribute to numerous disease states.
-  * **tetracycline antibiotics** – Family of bacteriostatic antibiotics, a few of which are used by the Marshall Protocol, including clindamycin, demeclocycline, and minocycline. So-called bacterial resistance to the tetracyclines is overcome with the concurrent use of a Vitamin D Receptor agonist, olmesartan (Benicar) and [[home:protocol:mp_antibiotics:dosing|pulsing the antibiotics at low doses]]. 
   * **therapeutic probe* ** – A brief trial of the Marshall Protocol to see if it will generate an immunopathological response. The "gold standard" for testing whether a patient is a good candidate for the MP.   * **therapeutic probe* ** – A brief trial of the Marshall Protocol to see if it will generate an immunopathological response. The "gold standard" for testing whether a patient is a good candidate for the MP.
   * **TLR2** – A receptor which is expressed on the surface of certain cells and recognizes native or foreign substances and passes on appropriate signals to the cell and/or the nervous system. Part of the body's innate immune response.   * **TLR2** – A receptor which is expressed on the surface of certain cells and recognizes native or foreign substances and passes on appropriate signals to the cell and/or the nervous system. Part of the body's innate immune response.
Line 92: Line 85:
   * **vitamin D2** – Form of vitamin D created by plants and fungi. When ingested, the secosteroid is (sometimes) converted into 25-D. Also known as ergocholecalciferol.   * **vitamin D2** – Form of vitamin D created by plants and fungi. When ingested, the secosteroid is (sometimes) converted into 25-D. Also known as ergocholecalciferol.
   * **vitamin D3** – Form of vitamin D made in the skin when exposed to light. Also available in fish and meat. This secosteroid is sometimes converted into 25-D. Also known as cholecalciferol and activated 7-dehydrocholesterol.   * **vitamin D3** – Form of vitamin D made in the skin when exposed to light. Also available in fish and meat. This secosteroid is sometimes converted into 25-D. Also known as cholecalciferol and activated 7-dehydrocholesterol.
-  * **VDR agonist** - A substance such as olmesartan (Benicar) or 1,25-D which activates the Vitamin D Receptor and transcribes the genes necessary for a proper innate immune response.+  * **VDR agonist** - A substance such as olmesartan (Benicar) or 1,25-D which activates the Vitamin D Receptor enabling transcription of the genes necessary for a proper innate immune response.
   * **VDR antagonist** - A substance such as 25-D or certain bacterial ligands which inactivates the Vitamin D Receptor, the receptor which transcribes the genes necessary for a proper innate immune response.   * **VDR antagonist** - A substance such as 25-D or certain bacterial ligands which inactivates the Vitamin D Receptor, the receptor which transcribes the genes necessary for a proper innate immune response.
  
home/patients/glossary.txt · Last modified: 10.13.2018 by sallieq
© 2015, Autoimmunity Research Foundation. All Rights Reserved.